350AAASLD ABSTRACTSHEPATOLOGY, October, 2013
come of HBV-ACLF, which may be beneficial for adjusting ther-apy strategy on time.
Disclosures:
The following people have nothing to disclose: Wei Lin, Chenggang Jin, XiaohuiLiu, Jinqiu He, Ming Li, Shuqin Zhang, Yuexin Zhang, Hong Chen, ChangqingZhang, Lixia Ma, Xinhuan Wei, Haiqing Guo, Zhen Li, Wenfang Wu, Jinhua Hu,Qinghua Meng, Huiguo Ding, Yu Chen, Sujun Zheng, Shuang Liu, Jing Zhang,Zhongping Duan
287
A novel hepato-proliferative effect of carbamazepineduring liver regeneration
Tsukasa Kawaguchi, Takahiro Kodama, Satoshi Tanaka, KaoriMukai, Satoshi Aono, Minoru Shigekawa, Satoshi Shimizu, HayatoHikita, Wei Li, Takuya Miyagi, Naoki Hiramatsu, Tomohide Tat-sumi, Tetsuo Takehara; Gastroenterology and Hepatology, OsakaUniversity Graduate School of Medicine, Osaka, Japan
Background and Aims: Liver regeneration after surgical resec-tion or injury is a complex phenomenon primarily dependent onhepatocyte proliferation. If this fundamental proliferative abilityis not sufficient to compensate for the resected or injured liver,liver failure will occur, which remains an important clinicalproblem. To overcome this, it is important to explore a thera-peutic agent supporting liver regeneration. Carbamazepine(CBZ) is widely used in the treatment of neuropsychiatric disor-ders as an anticonvulsant. A recent report revealed that CBZhas an anti-fibrotic effect on the livers of α1-antitrypsin-deficientmice, raising the possibility of a hepatology-related therapeuticuse for the drug. In addition, although CBZ modulates neuronalcell proliferative signalling, its effect on liver regeneration hasnever been studied. In the present study, we investigated aneffect of CBZ on liver regeneration after surgical resection orinjury. Methods: Six- to 8-week-old male C57BL6/J mice weregiven oral administration of CBZ or vehicle and underwent70% partial hepatectomy (PHx). Their liver to body weightratio, hepatocyte proliferation, and activation of signaling path-ways were assessed during liver regeneration. Mice were alsosubjected to an intraperitoneal injection of carbon tetrachloride(CCl4) after CBZ or vehicle treatment and their hepatocyte pro-liferation was evaluated. Results: Liver to body weight ratio wasrapidly recovered in the CBZ-treated mice and significantlyhigher than in the vehicle-treated mice at 2-5 days after PHx.The number of Ki-67 positive nuclei and that of BrdU were sig-nificantly higher in CBZ-treated mice than in vehicle-treatedmice at 48 and 36 hours after PHx, respectively. Western blotanalysis also revealed that levels of PCNA protein expressionwere much higher in CBZ-treated mice than in vehicle-treadedmice at 24 and 48 hours after PHx. PHx surgery induced sev-eral cyclin expression with activation of mTOR and its down-stream signaling including S6K and 4EBP1, all of which wereenhanced by CBZ treatment. Administration of m-TOR inhibitor,temsirolimus, which could block activation of S6K and 4EBP1 inthe hepatectomized mice, abrogated the hepato-proliferativeeffect of CBZ. CBZ treatment also enhanced hepatocyte prolif-eration as evaluated by PCNA protein expression at 48 hoursafter CCl4 injection. Conclusion: CBZ demonstrated a novelhepato-proliferative effect during liver regeneration after PHxand acute liver injury. CBZ may have the potential to be a ther-apeutic option for facilitating efficient liver regeneration inpatients subjected to liver surgery or injury.
Disclosures:
Tetsuo Takehara - Grant/Research Support: Chugai Pharmaceutical Co., MSDK.K.
The following people have nothing to disclose: Tsukasa Kawaguchi, TakahiroKodama, Satoshi Tanaka, Kaori Mukai, Satoshi Aono, Minoru Shigekawa,Satoshi Shimizu, Hayato Hikita, Wei Li, Takuya Miyagi, Naoki Hiramatsu, Tomo-hide Tatsumi
288
Acute hepatitis E Caused by Monophyletic HEV StrainResponsible for Remerged Epidemics in Sapporo, Japan
Jong-Hon Kang1,6, Yoshiyasu Karino2,6, Hitoshi Mizuo3,6, TakeshiMatsui1,6, Kazuaki Takahashi4,6, Masahiro Arai4,6, HiroakiOkamoto5,6, Shunji Mishiro4,6; 1Center for Gastroenterology, TeineKeijinkai Hospital, Sapporo, Japan; 2Department of Hepatology,Sapporo Kosei General Hospital, Sapporo, Japan; 3Department ofInternal Medicine, Kin-Ikyo Chuo Hospital, Sapporo, Japan;4Department of Medical Sciences, Toshiba General Hospital,Tokyo, Japan; 5Division of Virology, Department of Infection andImmunity, Jichi Medical University School of Medicine, Shimotsuga,Japan; 6Hokkaido Study Group for Hepatitis E, Sapporo, Japan
Background / Aims: Acute sporadic hepatitis E can occurindigenously even in the industrialized countries, but not likelyfor epidemic or outbreak. Sapporo has been considered asone of the most prevalent regions for hepatitis E virus (HEV) inJapan. During the regional surveillance for hepatitis E, we haveencountered an epidemic of hepatitis E two times in Sapporowith a two-year interval. HEV sequences from patients segre-gated to a compact cluster in genotype 4, “New Sapporostrain”, suggesting a single-source transmission responsible forthe epidemics. The aim of this study is to clarify the clinical andvirological characteristics of the new Sapporo strain thosecaused reemerging epidemics. Methods: From 2007 until2012, a total of 109 patients were prospectively diagnosed asautochthonous hepatitis E out of 465 patients with non A, nonB, non C acute liver injury registered from 44 hospitals cover-ing the whole regions of Hokkaido prefecture. HEV infectionwas diagnosed by HEV RNA and/or anti-HEV antibodies (IgMand/or IgA) in sera. Acute liver failure (ALF) was defined to bea case with prothrombin time INR more than 1.5. A phyloge-netic analysis was performed based on a 326-nt sequencewithin ORF1 of HEV genome. Results: Out of 109 cases of hep-atitis E thus collected in Hokkaido, 68 were from Sapporo andits suburbs. Among them, 27 sporadic patients (16 males,median age 55 years) were confirmed to infect with new Sap-poro strain by phylogenetic analysis. Out of 27 patients, 11from September to October 2009 and 12 from late December2011 to June 2012 emerged consecutively, and 13 (48.1%)developed ALF, 1 presented fulminant progression. The com-mon infection route of HEV was not found, in spite of minuteresearch for the patients and their families. Among 27 patientsinfected with monophyletic HEV, male gender (n=10,p=0.0719) and mean alcohol consumption (35.2 g/day asethanol, p=0.0423) were associated with ALF development incomparison with those in the patients with self-limited course.Quantified HEV levels in the early sera sampled within 7 daysafter the onset may be higher in ALF cases than those with self-limited (5.91+/- 0.40 vs. 4.96+/- 0.97 log copies /ml,p=0.0616). Peak AST levels were correlated with quantifiedHEV RNA in the first sera obtained within the same period(r=0.0692, p=0.0048, Y=0.333X+1.603). Conclusion: Thisstudy demonstrates male gender and pre-existing alcoholic liverdisease can be related disease progression in the acute HEVinfection of monophyletic strain within genotype 4. In addition,on the disease onset, rapid replication of HEV genome mayinduce striking immune response followed by serious hepatitis.
Disclosures:
Hitoshi Mizuo - Management Position: Viral Hepatitis Division Department ofInternal Me
The following people have nothing to disclose: Jong-Hon Kang, Yoshiyasu Karino,Takeshi Matsui, Kazuaki Takahashi, Masahiro Arai, Hiroaki Okamoto, ShunjiMishiro
The n e w e ng l a n d j o u r na l of m e dic i n e review article CRITICAL CARE MEDICINE Acute Liver Failure cute liver failure is a...
Gene Therapy for Acute Liver Failure Current Gene Therapy, 2010, Vol. 10, No. 2 157 tential therapeutic targets involved in the pathogenesis of ALF in...
Liver failure Hyper - acute liver failure Acute liver failure Greatest risk of cerebral oedema, CVS failure Greatest chance of spontaneous survival Sub - ...
If acute liver failure due to a pregnancy-related cause (such as acute fatty liver of pregnancy) is a possible differential diagnosis, urgent delivery of...
APASL Acute-on-chronic liver failure_临床医学_医药卫生_专业资料 暂无评价0人阅读0次下载举报文档 APASL Acute-on-chronic liver failure_临床医学_医药卫生...
PFIC type III in infant presenting as acute liver cell failure 2010_临床医学_医药卫生_专业资料。case report PFIC type III in infant presenting as acute ...
Acute Renal Failure_基础医学_医药卫生_专业资料。Acute Renal Failure ? Definition...after restoration of hepatic function after liver transplantation Type I HRS...
哪几肝衰竭分为急性肝衰竭(acute liver failure, ALF) ,亚急性肝衰竭(subacute liver failure, SALF)和慢性肝衰竭(chronic liver failure, CLF) 。 急性肝衰竭 ...
pregnancy, AFLP)是妊娠晚期特发的严重肝脏损害又名为妊娠期 特发性脂肪肝(Idiopathic acute fatty liver of pregnancy)或妊娠期急性肝衰竭(acute liver failure) ...
急性肝衰竭的处理(AASLD 指导意见) 王宇明 晏泽辉 导言 《急性肝衰竭(acute liver failure, ALF)的处理》的推荐意见建立在一种证据分级的标准上。 作者采用了...
热门文档